Related Experiment Video
Updated: Sep 25, 2025

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
Published on: June 3, 2018
LKB1 suppression promotes cardiomyocyte regeneration via LKB1-AMPK-YAP axis
Shuang Qu1, Qiao Liao1, Cheng Yu1
1Department of Cardiology, Daping Hospital, The Third Military Medical University, Chongqing, China; Chongqing Key Laboratory for Hypertension Research, Chongqing Cardiovascular Clinical Research Center, Chongqing Institute of Cardiology, Chongqing, China.
Abstract:
The regenerative potential of cardiomyocytes in adult mammals is limited. Previous studies reported that cardiomyocyte proliferation is suppressed by AMP-activated protein kinase (AMPK). The role of liver kinase B1 (LKB1), as the major upstream kinase for AMPK, on cardiomyocyte proliferation is unclear. In this study, we found that the LKB1 levels rapidly increased after birth. With loss- and gain-of-function study, our data demonstrated that LKB1 levels negatively correlate with cardiomyocyte proliferation. We next identified Yes-associated protein (YAP) as the downstream effector of LKB1 using high-throughput RNA sequencing. Our results also demonstrated that AMPK plays an essential role in Lkb1 knockdown-induced cardiomyocyte proliferation. Importantly, deactivated AMPK abolished the LKB1-mediated regulation of YAP nuclear translocation and cardiomyocyte proliferation. Thus, our findings suggested the role of LKB1-AMPK-YAP axis during cardiomyocyte proliferation, which could be used as a potential target for inducing cardiac regeneration after injury.
Insights
Liver kinase B1 (LKB1) inhibits cardiomyocyte proliferation by activating AMP-activated protein kinase (AMPK), which regulates Yes-associated protein (YAP). This LKB1-AMPK-YAP axis offers a target for cardiac regeneration.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Regenerative Medicine
Background:
- Limited regenerative capacity of cardiomyocytes in adult mammals.
- AMP-activated protein kinase (AMPK) suppresses cardiomyocyte proliferation.
- The role of upstream kinase liver kinase B1 (LKB1) in this process remains unclear.
Purpose of the Study:
- To investigate the role of LKB1 in cardiomyocyte proliferation.
- To elucidate the molecular mechanisms linking LKB1 to cardiomyocyte proliferation.
- To identify potential therapeutic targets for cardiac regeneration.
Main Methods:
- Loss- and gain-of-function studies of LKB1 in cardiomyocytes.
- High-throughput RNA sequencing to identify downstream effectors.
- Assessment of AMPK activity and YAP nuclear translocation.
Main Results:
- LKB1 levels increase postnatally and negatively correlate with cardiomyocyte proliferation.
- Yes-associated protein (YAP) identified as a downstream effector of LKB1.
- AMPK is essential for LKB1 knockdown-induced proliferation and mediates LKB1's regulation of YAP.
Conclusions:
- The LKB1-AMPK-YAP signaling axis regulates cardiomyocyte proliferation.
- LKB1 inactivation promotes proliferation via AMPK-mediated YAP regulation.
- Targeting the LKB1-AMPK-YAP pathway may enhance cardiac regeneration.
Related Concept Videos
cAMP-dependent Protein Kinase Pathways
PI3K/mTOR/AKT Signaling Pathway

